François Curtin is a seasoned biopharmaceutical executive, currently serving as CEO & COO at GeNeuro SA. He combines a robust medical background, including an MD from the University of Geneva and an MPhil from the London School of Hygiene, with business expertise from an MBA and prior director roles in development and licensing at Merck Serono.
He is also the founder and chairman of Iremis therapeutics, a clinical-stage spin-off from the University of Geneva focused on developing treatments for neuropathic pain.
Unique fact: His work at GeNeuro focuses on the novel approach of treating neurodegenerative diseases by targeting pathogenic proteins expressed by human endogenous retroviruses (HERVs).
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.